Indivior Pharmaceuticals Inc (INDV.L) LSE
1,238.00
+19(+1.56%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Indivior Pharmaceuticals Inc
Address
10710 Midlothian Turnpike
North Chesterfield, VA 23235
United States of America (the)
Phone
804 379 1090
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1030
First IPO Date
December 22, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Joseph J. Ciaffoni | Chief Executive Officer & Director | 3,007 | 1971 |
| Mark Crossley | Chief Executive Officer & Executive Director | 1.76M | 1970 |
| Ryan Preblick | Chief Financial Officer | 576,527 | 1976 |
| Christian Heidbreder | Chief Scientific Officer | 0 | 1963 |
| Hillel West | Chief Manufacturing & Supply Officer | 0 | 1968 |
| Jason Thompson | Vice President of Investor Relations | 0 | N/A |
| Jeffrey W. Burris | Chief Legal Officer | 0 | 1972 |
| Richard Simkin | Chief Commercial Officer | 0 | 1971 |
| Vishal Kalia | Chief Strategy & Operating Officer | 0 | 1981 |
| Angela Colon-Mahoney | Chief Human Resources Officer | 0 | 1976 |
| Cynthia Cetani | Chief Integrity & Compliance Officer | 0 | 1966 |
Description
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
